USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
15.30
-7.48 (-32.84%)
Aug 5, 2026, 12:29 PM EDT - Market open
USANA Health Sciences Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 913.36 | 925.26 | 854.5 | 921.01 | 998.6 | 1,186 | |
Revenue Growth | 1.57% | 8.28% | -7.22% | -7.77% | -15.83% | 4.57% |
Cost of Revenue | 206 | 200.85 | 161.21 | 176.69 | 193.89 | 217.9 |
Gross Profit | 707.36 | 724.41 | 693.29 | 744.32 | 804.71 | 968.57 |
Selling, General & Admin | 665.88 | 673.54 | 626.97 | 651.25 | 697.1 | 798.37 |
Other Operating Expenses | - | 13.43 | - | - | - | - |
Total Operating Expenses | 665.88 | 686.97 | 626.97 | 651.25 | 697.1 | 798.37 |
Operating Income | -1.08 | 37.43 | 66.32 | 93.07 | 107.61 | 170.19 |
Interest Income | 2.11 | 2.42 | 11.32 | 9.64 | 3.79 | 2.52 |
Interest Expense | -0.41 | -0.84 | -0.28 | -0.26 | -0.19 | -0.06 |
Other Non-Operating Income (Expense) | 1.92 | 2.52 | -1.01 | 0.01 | -2.59 | -2.01 |
Total Non-Operating Income (Expense) | 3.62 | 4.1 | 10.03 | 9.38 | 1.01 | 0.45 |
Pretax Income | 2.54 | 41.53 | 76.35 | 102.45 | 108.62 | 170.64 |
Provision for Income Taxes | 31.79 | 30.05 | 34.29 | 38.67 | 39.27 | 54.14 |
Net Income | -29.25 | 11.48 | 42.06 | 63.79 | 69.35 | 116.51 |
Minority Interest in Earnings | -7.09 | 0.72 | 0.03 | - | - | - |
Net Income to Common | -22.16 | 10.76 | 42.03 | 63.79 | 69.35 | 116.51 |
Net Income Growth | - | -74.40% | -34.11% | -8.02% | -40.48% | -6.54% |
Shares Outstanding (Basic) | 18 | 19 | 19 | 19 | 19 | 20 |
Shares Outstanding (Diluted) | 18 | 19 | 19 | 19 | 19 | 20 |
Shares Change | -3.06% | -3.07% | -0.95% | 0.18% | -5.08% | -4.29% |
EPS (Basic) | -1.21 | 0.58 | 2.20 | 3.31 | 3.60 | 5.78 |
EPS (Diluted) | -1.21 | 0.58 | 2.19 | 3.30 | 3.59 | 5.73 |
EPS Growth | - | -73.52% | -33.64% | -8.08% | -37.35% | -2.22% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Free Cash Flow | - | 8.53 | 50.92 | 56.15 | 93.5 | 108.46 |
Free Cash Flow Growth | - | -83.26% | -9.31% | -39.95% | -13.79% | -25.36% |
Free Cash Flow Per Share | - | 0.46 | 2.66 | 2.90 | 4.84 | 5.33 |
Gross Margin | 77.45% | 78.29% | 81.13% | 80.82% | 80.58% | 81.63% |
Operating Margin | -0.12% | 4.05% | 7.76% | 10.11% | 10.78% | 14.34% |
Profit Margin | -3.20% | 1.24% | 4.92% | 6.93% | 6.94% | 9.82% |
FCF Margin | - | 0.92% | 5.96% | 6.10% | 9.36% | 9.14% |
EBITDA | -1.08 | 77.13 | 88.55 | 113.47 | 129.02 | 192.39 |
EBITDA Margin | -0.12% | 8.34% | 10.36% | 12.32% | 12.92% | 16.21% |
EBIT | -1.08 | 37.43 | 66.32 | 93.07 | 107.61 | 170.19 |
EBIT Margin | -0.12% | 4.05% | 7.76% | 10.11% | 10.78% | 14.34% |
Effective Tax Rate | 1253.35% | 72.36% | 44.91% | 37.74% | 36.15% | 31.73% |